Brief: Tarsus Announces Pricing Of Upsized $125 Million Public Offering
13/03/2025 01:50
March 12 (Reuters) - Tarsus Pharmaceuticals Inc TARS.O: TARSUS ANNOUNCES PRICING OF UPSIZED $125.0 MILLION PUBLIC OFFERING TARSUS PHARMACEUTICALS INC - PRICES UPSIZED PUBLIC OFFERING OF 2.8 MILLION SHARES AT $44.50/SHARE Source text: ID:nGNX28DY9P Further company coverage: TARS.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tarsus Pharmaceuticals
See all newsBrief: Lisata Therapeutics Appoints Jeff Farrow To Board Of Directors
Brief: Tarsus Pharmaceuticals Files For Offering Of Up To 2.91 Million Shares Of Common Stock By Selling Stockholders
U.S. RESEARCH ROUNDUP-Argan, Mastec, Oracle
Tarsus Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Tarsus to expand eye disease pipeline with up to $800 million Alkeus acquisition (updated)